The transaction secures a collection of high-quality medical facilities operated by Spire Healthcare, a dominant player in the British private hospital market. According to Marc Zahr, Blue Owl’s co-president and global head of real assets, the move serves to accelerate the firm's European net lease strategy by capitalizing on robust supply and demand fundamentals within the region’s healthcare sector.

Financing for the acquisition was provided through a secured term loan arranged by a banking syndicate including Standard Chartered Bank, Natixis, and Crédit Agricole CIB. Rothschild & Co acted as the exclusive financial advisor for Blue Owl, with Kirkland & Ellis and Hogan Lovells providing legal counsel. Blue Owl, which managed $315 billion in assets as of March 2026, intends to integrate the portfolio into its broader real assets platform to drive long-term value creation across its institutional investment channels.